Deciphering the Complex Molecular Pathogenesis of Myotonic Dystrophy Type 1 through Omics Studies
Omics studies are crucial to improve our understanding of myotonic dystrophy type 1 (DM1), the most common muscular dystrophy in adults. Employing tissue samples and cell lines derived from patients and animal models, omics approaches have revealed the myriad alterations in gene and microRNA express...
Main Authors: | Jorge Espinosa-Espinosa, Anchel González-Barriga, Arturo López-Castel, Rubén Artero |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/3/1441 |
Similar Items
-
Cellular Senescence and Aging in Myotonic Dystrophy
by: Yuhei Hasuike, et al.
Published: (2022-02-01) -
Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds
by: Ludovic Arandel, et al.
Published: (2017-04-01) -
Resveratrol corrects aberrant splicing of RYR1 pre-mRNA and Ca2+ signal in myotonic dystrophy type 1 myotubes
by: Massimo Santoro, et al.
Published: (2020-01-01) -
Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy
by: Estefanía Cerro-Herreros, et al.
Published: (2021-12-01) -
Transcriptomics-proteomics Integration reveals alternative polyadenylation driving inflammation-related protein translation in patients with diabetic nephropathy
by: Tingting Zhao, et al.
Published: (2023-02-01)